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Midlife and Late-Life Vascular Risk Factors and White Matter
Microstructural Integrity: The Atherosclerosis Risk in Communities
Neurocognitive Study
Melinda C. Power, ScD; Jonathan V. Tingle, BA; Robert I. Reid, PhD; Juebin Huang, MD; A. Richey Sharrett, MD; Josef Coresh, MD;
Michael Griswold, PhD; Kejal Kantarci, MD, MS; Clifford R. Jack, Jr, MD; David Knopman, MD; Rebecca F. Gottesman, MD;
Thomas H. Mosley, PhD
Background-—Diffusion tensor imaging measures of white matter (WM) microstructural integrity appear to provide earlier
indication of WM injury than WM hyperintensities; however, risk factors for poor WM microstructural integrity have not been
established. Our study quantifies the association between vascular risk factors in midlife and late life with measures of late-life WM
microstructural integrity.
Methods and Results-—We used data from 1851 participants in ARIC (Atherosclerosis Risk in Communities Study) who completed
3-T magnetic resonance imaging, including diffusion tensor imaging, as part of the ARIC Neurocognitive Study (ARIC-NCS). We
quantified the association among lipids, glucose, and blood pressure from the baseline ARIC visit (1987–1989, ages 44–65,
midlife) and visit 5 of ARIC (2011–2013, ages 67–90, late life, concurrent with ARIC-NCS) with regional and overall WM mean
diffusivity and fractional anisotropy obtained at ARIC visit 5 for ARIC participants. We also considered whether these associations
were independent of or modified by WM hyperintensity volumes. We found that elevated blood pressure in midlife and late life and
elevated glucose in midlife, but not late life, were associated with worse late-life WM microstructural integrity. These associations
were independent of the degree of WM hyperintensity, and the association between glucose and WM microstructural integrity
appeared stronger for those with the least WM hyperintensity. There was little support for an adverse association between lipids
and WM microstructural integrity.
Conclusions-—Hypertension in both midlife and late life and elevated glucose in midlife are related to worse WM microstructural
integrity in late life. ( J Am Heart Assoc. 2017;6:e005608. DOI: 10.1161/JAHA.117.005608.)
Key Words: blood pressure • epidemiology • leukoencephalopathy • risk factor • type 2 diabetes mellitus
V ascular risk factors may increase the risk of subsequentcognitive decline and dementia, with the strongest
evidence supporting a link between midlife vascular risk-factor
levels and late life cognition.1–3 In the absence of stroke,
subclinical brain injury likely mediates these associations.
Diffusion tensor imaging (DTI) quantifies the microstructural
integrity of white matter (WM),4 which almost certainly plays a
role in later life cognitive impairment,5,6 and so can be used to
assess subclinical brain injury. DTI also complements other
neuroimaging measures, namely measures of WM hyperinten-
sities (WMHs) or WM volumes, because it provides an
assessment of pathologic changes that precede and predict
the development of WMH or WM loss.7–12 Consequently,
changes to WM microstructural integrity provide an early
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indication of who is at risk of cerebral WM injury, including both
WMH and WM loss, and subsequent cognitive impairment.
Identifying risk factors for poor WM microstructural integrity
will help us understand the extent to which DTI-basedmeasures
are appropriate risk-stratification tools or surrogate outcomes
in clinical trials. As such, understanding risk factors for poorWM
microstructural integrity will be critical in efforts to prevent or
mitigate these adverse outcomes.
Given the link between measures of WM microstructural
integrity and subsequent development of WMHs, we hypoth-
esized that risk factors for poor WM microstructural integrity
and WMHs would be similar. Elevated blood pressure is
consistently associated with the presence, severity, and
progression of WMH, regardless of the timing of measure-
ment.13–18 Although diabetes mellitus and fasting glucose are
not typically associated with WMH in cross-sectional analy-
ses,19,20 previous diabetes mellitus and fasting glucose are
related to WMH progression and later WMH severity in
longitudinal analyses.16,18 Conversely, lipids do not appear to
be associated with severity or progression of WMH.16,19 In
comparison, existing studies evaluating the association
between these risk factors and WM microstructural integrity
are typically small and cross-sectional, and despite evidence of
a link between WM microstructural integrity and WMH, most
have not investigated whether the association is independent
of or modified by WMH. The goal of this study was to quantify
the association of midlife and late-life measures of vascular risk
factors with late-life WMmicrostructural integrity in a relatively
large sample of persons drawn from ARIC-NCS (Atherosclero-
sis Risk in Communities Neurocognitive Study) and to consider
whether the association is independent of or modified by WMH.
Methods
Study Population
The ARIC study is a longitudinal cohort study of 15 792
persons recruited between 1987 and 1989 (visit 1) from 4 US
communities: suburbs of Minneapolis, Minnesota; Forsyth
County, North Carolina; Washington County, Maryland; and
Jackson, Mississippi. In 2011–2013 (visit 5), all persons with
evidence of cognitive impairment and a stratified random
sample of other participants were invited to complete brain
magnetic resonance imaging (MRI) as part of ARIC-NCS.21 As
such, although the MRI subsample is enriched with persons
with cognitive impairment, use of derived sampling weights
allows estimation of what the effects would be had we obtained
MRI on all ARIC visit 5 participants. Our eligible sample
included those ARIC-NCS participants with valid DTI data,
excluding nonblack and nonwhite persons (n=6), black partic-
ipants from Maryland or Minnesota (n=9), persons disallowing
the use of genetic data (n=10), and persons with prior stroke
(n=66). Primary analyses also excluded persons missing
exposure or covariate data; we considered associations in
the full eligible sample after multiply imputing missing data in
sensitivity analyses. The institutional review boards of all
participating institutions approved this study, and participants
provided written informed consent before participation.
Brain Imaging
At ARIC-NCS, each study site followed identical protocols for
3-T brain MRI. All scans included sagittal T1-weighted MPRAGE
(magnetization-prepared rapid gradient-echo imaging), axial T2
FLAIR (fluid attenuation inversion recovery), and axial DTI pulse
sequences. Data were processed by the ARIC MRI Reading
Center at the Mayo Clinic (Rochester, MN). We provide an
overview below (see Supplementary Methods for details).
Fractional anisotropy (FA) measures the directional con-
straint of water diffusion and ranges from 0 to 1 (unitless).
Mean diffusivity (MD) is a scalar measure of how quickly water
molecules diffuse overall (mm2/s). Lower FA and higher MD
indicate worse WM microstructural integrity. WM FA and MD
were calculated for brain regions defined by an in-house atlas
of lobar and deep WM regions based on the STAND400
template.22 The WM regions were intersected with tissue
segmentations from each participant’s T1-weighted and FLAIR
Clinical Perspective
What Is New?
• Diffusion tensor imaging quantifies the microstructural
integrity of white matter in the brain.
• Changes to brain white matter microstructural integrity
provide an early indication of who is at risk of cerebral white
matter injury and subsequent cognitive impairment.
• We found elevated glucose in midlife and elevated blood
pressure at both midlife and late life were associated with
worse brain white matter microstructural integrity. These
associations were largely independent of the severity of
white matter hyperintensities, a marker of cerebral white
matter injury.
• Lipid levels at midlife or late life were not associated with
brain white matter microstructural integrity.
What Are the Clinical Implications?
• Avoiding elevated glucose in midlife and hypertension at any
point may prevent later damage to brain white matter
microstructural integrity and its downstream effects.
• Diffusion tensor imaging–based measures may be appropri-
ate risk-stratification tools or surrogate outcomes in clinical
trials intervening with regard to vascular risk factors.
• Additional work is required to confirm these findings and to
better establish the utility of these markers.
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images; WM FA and MD were calculated using voxels with a
>50% probability of being WM. The segmentation takes care
to include WMHs as WM. To account for imperfect registration
between the DTI and T1-weighted images, an upper cutoff of
MD <0.002 mm2/s was applied to exclude edge voxels that
were primarily cerebrospinal fluid. We averaged left and right
WM FA and MD across atlas regions and then took a weighted
average, with weights based on the number of voxels in each
WM region, to create WM FA and MD measures for 7 regions
of interest (ROIs): frontal, temporal, occipital, and parietal
lobes; anterior and posterior corpus callosum; and an overall
measure—the weighted average of these 6 ROIs (capsular
WM was not included). WMH and intracranial volumes were
quantified via in-house algorithms.23,24
Vascular Risk Factors
We considered vascular risk factors at ARIC visit 1 (1987–
1989, midlife, ages 44–65) and ARIC visit 5 (2011–2013, late
life, ages 67–90). Plasma total cholesterol and triglycerides
were measured using enzymatic methods,25,26 high-density
lipoprotein cholesterol (HDL-C) concentrations were deter-
mined after precipitation of non-HDL lipoproteins,27,28 and
low-density lipoprotein cholesterol (LDL-C) levels were calcu-
lated using the Friedewald equation.29 Serum glucose was
measured using the hexokinase method.30 Systolic blood
pressure (SBP) and diastolic blood pressure (DBP) were
measured 3 times according to a standard protocol; we
consider the mean of the 2 final measurements.
Covariates
All covariates are based on data collected at ARIC visit 1 or at
ARIC visit 5 and include age (years), sex (male, female), race
and center (black–Mississippi, black–North Carolina, white–
North Carolina, white–Maryland, white–Minnesota), education
(less than high school/high school, General Educational
Development test, vocational school, some college/college,
graduate or professional school), APOE*E4 allele status
(present, absent), body mass index (kg/m2), smoking status
(current, former, never), antihypertensive medication use (yes,
no), lipid-lowering medication use (yes, no), and diabetes
mellitus medication use (yes, no). Medication use was
determined through direct visual inspection and linkage to
Medi-Span therapeutic classification codes.
Statistical Methods
We standardized ROI WM FA and MD by subtracting the
sample mean and dividing by the sample standard deviation.
For our primary analyses, we used separate weighted linear
regression models to quantify the association between each
vascular risk factor and WM FA and MD in each ROI. The
weights account for the approach used to select ARIC
participants for MRI. Given slight deviations from a linear
dose-response pattern for some exposures in exploratory
analyses, we considered associations with both categorical
and linear exposure parameterizations. All analyses were
adjusted for the covariates described above and the other
vascular risk factors (eg, SBP, DBP, and glucose in models
estimating associations with lipids). Time-varying covariates
were updated to reflect the status at the time of exposure
assessment (eg, visit 1 age when considering visit 1 SBP, visit
5 age for visit 5 SBP). We then adjusted these primary models
for total WMH volumes and intracranial volume to determine
whether our associations were independent of WMH severity.
We conducted several sensitivity analyses. We repeated
analyses considering glucose and lipids after restricting those
who were fasting ≥8 hours at blood draw (98% at visit 1, 96%
at visit 5). We repeated analyses for glucose and blood
pressure adjusting for total cholesterol, HDL-C, and triglyc-
erides rather than LDL-C. We restricted analyses of triglyc-
erides to those with <500 mg/dL triglycerides to exclude
potentially influential outliers. We considered analyses after
multiply imputing missing exposure and covariate data31 to
understand the influence and missing data. Finally, we
considered unweighted analyses to understand the influence
of the selection process by which we selected visit 5
participants for MRI and analyses additionally weighted with
inverse probability of attrition weights32,33 to better under-
stand the potential influence of potentially informative
attrition from visit 1 to visit 5 on our results.
We used multiplicative interaction terms to evaluate effect
modification by age (<75 or ≥75 years), race (black or white),
sex (male or female), APOE*E4 (present or absent), cognitive
status (normal/mild cognitive impairment or dementia), and
WMH severity (deciles of intracranial volume-standardized
WMH volumes). We considered P<0.05 to be statistically
significant and reported 95% confidence intervals. We did not
adjust for multiple comparisons, given that the association
between a vascular risk factor at a given time point and 1
measure of WM microstructural integrity is likely correlated
with associations considering other time points or ROIs. All
analyses were completed using SAS version 9.4, STATA
version 14.0, or R version 3.1.2.
Results
Weighted characteristics of the 1851 eligible persons are
provided in Table. Mean SBP and glucose were higher at visit
5 than at visit 1, whereas mean DBP, total cholesterol, and
LDL-C were lower. Tables S1 and S2 provide unweighted
summary statistics and information on missingness.
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Table. Weighted Characteristics of Eligible ARIC-NCS Participants at Visits 1 and 5 (n=1851)
Visit 1 (1987–1989) Visit 5 (2011–2013)
P Value†Mean (25th, 75th Percentile) or %*
Time to MRI, y 23.6 (23.0, 24.2) 0 (0, 0) 
Age, y 51.7 (46.8, 55.1) 75.3 (70.4, 78.7) <0.0001
Cognitively normal  74.1% 
APOE*E4 allele 27.4% 
Male 38.5% 
Race-center 
White-Minnesota 29.9%
White-Maryland 27.6%
White-North Carolina 21.2%
Black-North Carolina 1.7%
Black-Mississippi 19.6%
Education 
<12 y 11.8%
12–16 y 40.3%
>16 y 47.9%
Smoking status <0.0001
Current 16.6% 5.2%
Former 33.2% 51.6%
Never 50.2% 43.1%
Body mass index, kg/m2 26.8 (23.3, 29.3) 28.4 (24.7, 31.2) <0.0001
Systolic blood pressure, mm Hg 114.8 (103.7, 122.9) 129.8 (117.1, 140.1) <0.0001
Diastolic blood pressure, mm Hg 72.2 (64.7, 78.0) 66.0 (58.6, 72.3) <0.0001
Fasting glucose, mg/dL 99.4 (90.9, 102.8) 112.0 (96.9, 117.2) <0.0001
Total cholesterol, mg/dL 209.6 (182.0, 231.2) 185.9 (155.2, 212.4) <0.0001
HDL-C, mg/dL 54.2 (42.0, 63.1) 53.4 (43.0, 61.6) 0.007
LDL-C, mg/dL 132.2 (107.5, 154.5) 107.4 (81.3, 128.3) <0.0001
Triglycerides, mg/dL 117.3 (71.3, 139.8) 125.7 (85.2, 147.9) <0.0001
Antihypertensive medication use 20.2% 72.6% <0.0001
Medication use for diabetes mellitus 1.7% 18.5% <0.0001
Lipid-lowering medication use 1.6% 51.9% <0.0001
Hypercholesterolemia 57.3% 34.9% <0.0001
Fractional anisotropy, by region
Frontal  0.28 (0.27, 0.30) 
Temporal  0.28 (0.27, 0.30) 
Parietal  0.30 (0.29, 0.31) 
Occipital  0.22 (0.20, 0.24) 
Anterior corpus callosum  0.43 (0.39, 0.47) 
Posterior corpus callosum  0.58 (0.54, 0.62) 
Overall  0.28 (0.27, 0.30) 
Continued
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Findings were generally consistent across ROIs, sensitivity
analyses, and categorical and linear versions of the exposures
(Figures S1 through S28; Tables S3 through S5). We reported
the linear association between our vascular risk factors and
overall WM MD or FA in the next sections and discussed other
analyses only when they differed substantially from these
analyses. Likewise, we discussed effect measure modification
by age, sex, or race only when there was evidence supporting
its presence.
Plasma Lipids
Although there was little support for an adverse association
between elevated lipids at visit 1 and overall WM FA, elevated
total cholesterol, LDL-C, and HDL-C at visit 5 appeared to be
associated with better overall WM FA (Figure 1). However,
these protective associations were limited to those who
remained cognitively normal at visit 5 (interaction P<0.05,
with the exception of P=0.08 for visit 5 HDL-C) and were
attenuated in sensitivity analyses omitting sampling weights
or weighting for attrition, which upweight persons with
cognitive impairment (Figures S6, S10, and S14). Findings
were materially unchanged after adjustment for WMH
(Figure 1), and there was little support for effect modification
by WMH volumes (Figures S29 through S32). Analyses
considering effect modification suggested an association
between higher visit 5 triglycerides and worse overall FA in
women but not men (interaction P=0.004).
Visit 1 and 5 plasma lipids were not associated with overall
WM MD, with the exception of an adverse association with
Figure 1. Comparison of primary and WMH-adjusted
analyses of the association of mid- or late-life cardiovas-
cular risk factors with overall WM FA. CI indicates
confidence interval; DBP, diastolic blood pressure; FA,
fractional anisotropy; HDL-c, high-density lipoprotein
cholesterol; LDL-c, low-density lipoprotein cholesterol;
SBP, systolic blood pressure; WM, white matter; WMH,
white matter hyperintensity.
Figure 2. Comparison of primary and WMH-adjusted
analyses of the association of mid- or late-life cardiovas-
cular risk factors with overall WM MD. CI indicates
confidence interval; DBP, diastolic blood pressure; HDL-c,
high-density lipoprotein cholesterol; LDL-c, low-density
lipoprotein cholesterol; MD, mean diffusivity; SBP, systolic
blood pressure; WM, white matter; WMH, white matter
hyperintensity.
Table. Continued
Visit 1 (1987–1989) Visit 5 (2011–2013)
P Value†Mean (25th, 75th Percentile) or %*
Mean diffusivity, by region, 104 mm2/s
Frontal  8.5 (8.2, 8.9) 
Temporal  8.8 (8.4, 9.2) 
Parietal  8.8 (8.3, 9.1) 
Occipital  8.7 (8.2, 9.1) 
Anterior corpus callosum  11.5 (10.7, 12.2) 
Posterior corpus callosum  11.2 (10.4, 11.8) 
Overall  8.7 (8.3, 9.1) 
ARIC-NCS indicates Atherosclerosis Risk in Communities Neurocognitive Study; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MRI, magnetic
resonance imaging.
*Summary measures among those with data for a given variable.
†Comparing visits 1 and 5 using a weighted paired t test or McNemar test, as appropriate.
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elevated triglycerides at visit 5 (Figure 2); however, this result
was not robust to sensitivity analyses omitting sampling
weights or imputing missing data (Figure S4). Adjustment for
WMH did not alter these findings (Figure 2). Some evidence
suggested an association between elevated LDL-C and worse
overall WM FA and MD only in those in the highest decile of
standardized WMH volumes (Figure S30). Analyses consider-
ing effect modification also suggested a protective associa-
tion between visit 1 HDL-C and overall WM MD in black but
not white participants (interaction P=0.01).
Serum Glucose
Elevated serum glucose at visit 1 was strongly associated with
worse overall WM MD (Figure 2). Although elevated glucose
at visit 1 was marginally associated with worse overall WM FA
(Figure 1), analyses considering categories of glucose did not
support an association (Table S4). Visit 5 glucose was not
associated with overall WM FA or MD, except in sensitivity
analyses implementing inverse probability of attrition weight-
ing, where higher visit 5 glucose was associated with worse
overall WM MD. Results were similar after additional adjust-
ment for WMH (Figures 1 and 2), and the adverse association
between elevated visit 1 glucose and worse MD or FA was
stronger in those with the least WMH (Figures 3 and 4).
Blood Pressure
Elevated SBP and DBP at either visit were strongly associated
with worse overall WM FA and MD. Additional adjustment for
WMH slightly attenuated, but did not eliminate, these
associations (Figures 1 and 2). There was little support for
effect modification by WMH volumes (Figures 3 and 4). Of
note, in ROI-specific analyses, associations with MD or FA in
the anterior or posterior corpus callosum were often weaker
or null, and the association between visit 1 DBP and MD was
attenuated slightly in inverse probability of attrition weighting
sensitivity analyses (Figures S21 through S28).
Figure 3. The adjusted association between cardiovascular risk factors at visit 1
or 5 and measures of overall white matter fractional anisotropy by decile of
intracranial-volume standardized WMH volumes. CI indicates confidence interval;
DBP, diastolic blood pressure; SBP, systolic blood pressure; WMH, white matter
hyperintensity.
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Discussion
To our knowledge, this study of the relation of vascular risk
factors and WM microstructural integrity is the largest and
most comprehensive to date. Consistent with our own findings
that elevated blood pressure at both midlife and late life was
associated with worse WM microstructural integrity, several
small cross-sectional studies also previously reported an
association between elevated blood pressure and worse WM
microstructural integrity.7,34–42 Our finding of an association
between midlife glucose and late-life WM microstructural
integrity is also consistent with 1 prior report of stronger
associations between diabetes mellitus and WM microstruc-
tural integrity with increasing duration of diabetes mellitus.43
Although we did not observe a cross-sectional association
between glucose and WMmicrostructural integrity, prior cross-
sectional studies generally reported worse microstructural
integrity in participants with diabetes mellitus compared with
controls.43–48 Given that these studies were modest in size
(n<250), focused on diabetes mellitus rather than glucose, and
often reported effects only in localized brain regions, further
work will be needed to reconcile these findings with our own.
Finally, although we found little support for an adverse
association between elevated lipids and late-life WM
microstructural integrity, prior reports are mixed, with studies
reporting both null and adverse associations between lipids and
WM microstructural integrity.47,49–51 As with the literature on
diabetes mellitus and WM microstructural integrity, however,
these studies frequently report localized effects, which may not
be reflected in our analyses, given our focus on large ROIs, and
are limited by their size (n<250). Our finding that associations
between vascular risk factors and WMmicrostructural integrity
were largely independent of WMH volumes is also consistent
with some prior reports,43,45,47 reinforcing the notion that WM
microstructural integrity damage likely precedes WMH.
Our findings underscore the importance of moving to
longitudinal designs that can answer questions about when
exposures are relevant. Strengths of this study include the
large number participants, the use of data on midlife and
Figure 4. The adjusted association between cardiovascular risk factors at visit 1
or 5 and measures of overall white matter mean diffusivity by decile of
intracranial-volume standardized WMH volumes. CI indicates confidence interval;
DBP, diastolic blood pressure; SBP, systolic blood pressure; WMH, white matter
hyperintensity.
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late-life vascular risk factors, and a community-based sample.
Compared with a voxelwise comparison-based approach, our
ROI-based approach has a reduced chance of type I error and
greater reproducibility but is unlikely to identify localized
effects. Because we based our study on an MRI subsample,
selection bias is a potential concern; however, we do not
believe that this is a significant source of bias in this study
because our sensitivity analyses designed to address and
quantify this source of bias were generally consistent with our
primary analyses. Other limitations include the lack of serial
MRIs, precluding assessment change in FA or MD, and the
potential for chance findings or residual bias.
Changes to WM microstructural integrity provide an early
indication of who is at risk of cerebral WM injury, including both
WMH and WM loss, and subsequent cognitive impairment. Our
study confirmed that the risk factors for WM microstructural
integrity and WMH are similar, and that, perhaps most
important, these associations were independent of WMH
presence and severity. Although our study provides early
evidence to suggest that DTI-based measures may be appro-
priate outcomes risk-stratification tools or surrogate outcomes
in clinical trials intervening with regard to vascular risk factors,
additional work is required to confirm these findings and to
better establish the utility of these markers. Regardless, our
study suggests that avoiding elevated glucose in midlife and
hypertension at any point may prevent later damage to WM
microstructural integrity and its downstream effects.
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Supplementary Methods:  MRI Scan Parameters and Processing 
 
At Visit 5/ARIC-NCS, each study site followed similar protocols for 3T brain MRI.  The North 
Carolina and Mississippi sites used Skyras, the Maryland site used a Verio, and the Minnesota 
site used a Trio Tim, all manufactured by Siemens.  The T1-weighted volumetric scans used a 
sagittal magnetization prepared gradient echo (MPRAGE) sequence with 1.2mm x 1.0mm x 1.0 
mm resolution in the x (~LR), y (~AP), and z (~SI) directions.  The resulting images were 
unwarped in post-processing to account for gradient nonlinearity, using coefficients provided by 
the manufacturer. The FLAIR scans, primarily used to detect WMH, had a resolution of 0.9mm x 
0.9mm x 5.0mm in x, y, and z. The DTI scans used the Siemens product echo planar imaging 
(EPI) pulse sequence and diffusion gradient set, namely a single b = 0 volume followed by 64 b 
= 1000 s/mm2 diffusion directions uniformly spread over the whole sphere.  An isotropic 2.7mm 
voxel resolution was used, and DTI echo time (TE) was 87 ms for all scanners. 
 
In post-processing the DTI images were simultaneously corrected for volume-to-volume head 
motion and eddy current distortion by affinely registering each of the diffusion weighted 
volumes to the b=0 volume.  EPI sequences are also affected by distortions at changes in 
magnetic susceptibility, such as air/tissue/bone interfaces around the sinuses and ear canals.  
These distortions were corrected by nonlinearly registering the DTI images to the T1-weighted 
anatomical reference scan using the BrainSuite (Bhushan, Haldar, Choi, Joshi, Shattuck, & 
Leahy, 2015) program, which also produced FA and MD images in each subject’s T1-weighted 
space after fitting diffusion tensors to the data with a weighted least-squares scheme.  Each 
FLAIR-to-T1 and DTI-to-T1 registration was manually examined to catch and correct or remove 
gross registration failures. 
 
Image analysis for all four sites was completed by the ARIC MRI Reading Center (Mayo Clinic, 
MN;  PI: Dr. Cliff Jack, Jr.) using the same protocols, ensuring consistency of measurement 
across sites.  Finally, we also adjusted for site in our regression models, as part of the race-center 
variable.   
 
 
Reference: 
 
Bhushan, C., Haldar, J., Choi, S., Joshi, A., Shattuck, D., & Leahy, R. (2015). Co-registration 
and distortion correction of diffusion and anatomical images based on inverse contrast 
normalization. Neuroimage , 115, 269-80. 
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Table I.  Unweighted characteristics eligible ARIC-NCS sample participants at Visit 1 and Visit 5 (n=1851) 
 Visit 1 (1987-89) Visit 5 (2011-2013) 
 Mean (25th, 75th percentile) or %* Time to MRI (years) 23.7 (23.0, 24.2)  0 (0, 0) 
Age (years) 52.7 (47.7, 56.1)  76.4 (71.3, 79.9) 
Cognitively Normal N/A 59.4%  
APOE e4 allele (CT or CC) 29.2% 
Male 39.9% 
Race-center     
     MN whites 22.5% 
     MD whites  26.5% 
     NC whites  23.4% 
     NC blacks  1.8% 
     MS blacks 25.8% 
Education     
     <12 years 14.1%  
     12-16 years  40.9% 
     >16 years  44.9% 
Smoking status     
     Current 16.6%  5.4%  
     Former 32.4%  50.9%  
     Never  51.0% 43.7%  
BMI (kg2/m) 27.0 (23.6, 29.5)  28.4 (24.7, 31.1)  
Systolic BP (mm Hg) 116.2 (104.4, 124.5)  131.0 (118.0, 141.5) 
Diastolic BP (mm Hg) 72.8 (65.1, 79.5) 66.2 (58.7, 72.6) 
Fasting glucose (mg/dL) 100.0 (91.3, 103.2) 112.7 (96.9, 118.5) 
Total cholesterol (mg/dL) 212.7 (184.8, 234.3) 183.7 (153.3, 210.2) 
HDL cholesterol (mg/dL) 54.7 (41.4, 63.7) 53.0 (42.9, 61.0) 
LDL cholesterol (mg/dL) 134.7 (109.2, 156.9) 105.8 (80.2, 126.6) 
Triglycerides (mg/dL) 118.5 (72.5, 139.3) 125.2 (83.9, 146.6) 
Antihypertensive medication use 22.2% 74.9% 
Medication use for diabetes 1.9% 21.2% 
Lipid lowering medication use  1.7% 54.0% 
Hypercholesterolemia 61.2% 33.0% 
Fractional anisotropy, by region     
     Frontal -- 0.28 (0.27, 0.30) 
     Temporal --  0.28 (0.27, 0.30) 
     Parietal --  0.30 (0.28, 0.31) 
     Occipital --  0.22 (0.20, 0.23) 
     Anterior corpus callosum --  0.42 (0.38, 0.46) 
     Posterior corpus callosum --  0.57 (0.54, 0.62) 
     Overall --  0.28 (0.27, 0.30) 
Mean diffusivity, by region (10-4 mm2/s)     
     Frontal -- 8.6 (8.2, 8.9) 
     Temporal --  8.9 (8.5, 9.3) 
     Parietal --  8.8 (8.3, 9.2) 
     Occipital --  8.7 (8.3, 9.1) 
     Anterior corpus callosum --  11.6 (10.8, 12.4) 
     Posterior corpus callosum --  11.2 (10.4, 11.9) 
     Overall --  8.8 (8.4, 9.1) 
Abbreviations: ARIC-NCS, Atherosclerosis Risk in Communities Neurocognitive Study; MRI, magnetic 
resonance imaging 
*All summary measures among those with data for a given variable.  Number missing each variable is provided 
in Appendix Table 2. 
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7 
Table II.  Number of eligible ARIC-NCS sample participants missing covariate or exposure data at Visit 1 or 
Visit 5 
  Visit 1 (1987-89) Visit 5 (2011-2013) 
 N missing  Time to MRI (years) 0 0 
Age (years) 0 0 
Cognitively Normal N/A 13 
APOE e4 allele (CT or CC) 55 
Male 0 
Race-center 0 
Education 2 
Smoking status  0 117 
BMI (kg2/m) 1 8 
Systolic BP (mm Hg) 2 6 
Diastolic BP (mm Hg) 2 6 
Fasting glucose (mg/dL) 56 106 
Total cholesterol (mg/dL) 25 13 
HDL cholesterol (mg/dL) 24 13 
LDL cholesterol (mg/dL) 43 36 
Triglycerides (mg/dL) 24 13 
Antihypertensive medication use 0 0 
Medication use for diabetes 332 5 
Lipid lowering medication use 20 5 
Hypercholesterolemia 25 13 
Abbreviations: MRI, Magnetic resonance imaging  
*All summary measures among those with data for a given variable.  Number missing each variable is provided 
in Appendix Table 2. 
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Table III.  Adjusted associations between a 10-unit increase in the level of each vascular risk factor approximately 24 years prior to or 
concurrent with MRI and standardized measures of overall WM microstructural integrity on diffusion MRI in ARIC-NCS 
     Visit 1 (~24 years prior to MRI)  Visit 5 (Concurrent with MRI) 
    N beta (95%CI)* p-value N beta (95%CI)* p-value 
WM FA 
  Triglycerides (mg/dL) 1425 0.0024 (-0.0046, 0.0094) 0.50 1574 -0.0026 (-0.0104, 0.0052) 0.51 
  LDL-c (mg/dL) 1410 0.0017 (-0.0117, 0.0151) 0.81 1564 0.0156 (0.0011, 0.0302) 0.04 
  HDL-c (mg/dL) 1425 0.0255 (-0.0081, 0.0591) 0.14 1574 0.0340 (-0.0019, 0.0698) 0.06 
  Total Cholesterol (mg/dL) 1425 0.0053 (-0.0071, 0.0177) 0.40 1574 0.0129 (0.0009, 0.0249) 0.04 
  Glucose (mg/dL) 1425 -0.0292 (-0.0604, 0.0020) 0.07 1574 -0.0003 (-0.0199, 0.0193) 0.97 
  DBP (mmHg) 1425 -0.1077 (-0.1634, -0.0519) 0.0002 1574 -0.1195 (-0.1648, -0.0743) <0.0001 
  SBP (mmHg) 1425 -0.0481 (-0.0849, -0.0114) 0.01 1574 -0.0762 (-0.1019, -0.0506) <0.0001 
WM MD 
  Triglycerides (mg/dL) 1425 -0.0013 (-0.0069, 0.0044) 0.66 1574 0.0065 (0.0002, 0.0127) 0.04 
  LDL-c (mg/dL) 1410 -0.0028 (-0.0136, 0.0080) 0.61 1564 -0.0061 (-0.0178, 0.0056) 0.31 
  HDL-c (mg/dL) 1425 0.0005 (-0.0267, 0.0277) 0.97 1574 -0.0111 (-0.0399, 0.0176) 0.45 
  Total Cholesterol (mg/dL) 1425 -0.0028 (-0.0128, 0.0072) 0.59 1574 -0.0020 (-0.0117, 0.0076) 0.68 
  Glucose (mg/dL) 1425 0.0473 (0.0221, 0.0726) 0.0002 1574 0.0034 (-0.0124, 0.0191) 0.67 
  DBP (mmHg) 1425 0.0621 (0.0170, 0.1073) 0.007 1574 0.0720 (0.0356, 0.1084) 0.0001 
  SBP (mmHg) 1425 0.0465 (0.0168, 0.0761) 0.002 1574 0.0606 (0.0401, 0.0811) <0.0001 
Abbreviations:   ARIC-NCS, Atherosclerosis Risk in Communities Study Neurocognitive Study; DBP, diastolic blood pressure; FA, fractional 
anisotrophy; HDL-c, high density lipoprotein cholesterol;  LDL-c, low density lipoprotein cholesterol; MD, mean diffusivity; SBP, systolic 
blood pressure; WM, white matter 
*Fully adjusted model including age, gender, education, race/center, BMI, the square of BMI, smoking status, APOE E4, the other vascular 
risk factors, antihypertensive medication use, antidiabetic medication use, and lipid-lowering medications. 
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Table IV.  Adjusted difference in total FA by category of vascular risk factors measured at Visit 1 or Visit 5 
   Visit 1 (~24 years prior to MRI)  Visit 5 (Concurrent with MRI) 
  beta (95%CI) p-value beta (95%CI) p-value 
Triglycerides         
500+ mg/dL 0.3206 (-0.3586, 0.9998) 0.35 -0.2905 (-1.5258, 0.9449) 0.64 
200-500 mg/dL -0.0767 (-0.2471, 0.0937) 0.38 -0.07 (-0.219, 0.0791) 0.36 
150-200 mg/dL 0.113 (-0.0355, 0.2615)   -0.1156 (-0.2472, 0.016)   
<150 mg/dL 0 (ref) 0.14 0 (ref) 0.09 
LDL-c         
190+ mg/dL -0.0186 (-0.2393, 0.2021) 0.87 0.1672 (-0.1831, 0.5174) 0.35 
160-190 mg/dL 0.0026 (-0.166, 0.1712) 0.98 0.1947 (-0.0048, 0.3943) 0.06 
130-160 mg/dL 0.0437 (-0.0986, 0.1861) 0.55 0.0635 (-0.0777, 0.2046) 0.38 
100-130 mg/dL 0.0337 (-0.1022, 0.1696) 0.63 0.0526 (-0.0549, 0.1601) 0.34 
<100 mg/dL 0 (ref)   0 (ref)   
HDL-c         
60+ mg/dL 0.0931 (-0.0666, 0.2528) 0.25 0.0992 (-0.0514, 0.2498) 0.20 
40-60 mg/dL 0.0133 (-0.1217, 0.1483) 0.85 0.0527 (-0.0749, 0.1803) 0.42 
<40 mg/dL 0 (ref)   0 (ref)   
Total Cholesterol         
240+ mg/dL 0.0422 (-0.0877, 0.172) 0.52 0.0827 (-0.0694, 0.2348) 0.29 
200-240 mg/dL 0.0517 (-0.0577, 0.161) 0.35 0.0613 (-0.049, 0.1716) 0.28 
<200 mg/dL 0 (ref)   0 (ref)   
Glucose         
126+ mg/dL -0.0359 (-0.3913, 0.3195) 0.84 0.0092 (-0.1383, 0.1567) 0.90 
100-126 mg/dL -0.036 (-0.1416, 0.0696) 0.50 0.0022 (-0.0975, 0.1019) 0.97 
<100 mg/dL 0 (ref)   0 (ref)   
DBP         
80+ mm Hg -0.3137 (-0.5235, -0.1039) 0.003 -0.3487 (-0.5238, -0.1737) 0.0001 
60-80 mm Hg -0.2161 (-0.3901, -0.0422) 0.01 -0.1415 (-0.2439, -0.0392) 0.01 
<60 mm Hg 0 (ref)   0 (ref)   
SBP         
140+ mm Hg -0.1686 (-0.3852, 0.048) 0.13 -0.3448 (-0.4639, -0.2257) <0.0001 
120-140 mm Hg -0.1305 (-0.2449, -0.016) 0.03 -0.1863 (-0.2886, -0.084) 0.0004 
<120 mm Hg 0 (ref)   0 (ref)   
Abbreviations:   ARIC-NCS, Atherosclerosis Risk in Communities Study Neurocognitive Study; DBP, diastolic 
blood pressure; FA, fractional anisotrophy; HDL-c, high density lipoprotein cholesterol;  LDL-c, low density 
lipoprotein cholesterol;  SBP, systolic blood pressure.   
*Fully adjusted model including age, gender, education, race/center, BMI, the square of BMI, smoking status, 
APOE E4, the other vascular risk factors, antihypertensive medication use, antidiabetic medication use, and 
lipid-lowering medications. 
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Table V.  Adjusted difference in total MD by category of vascular risk factors measured at Visit 1 or Visit 5  
   Visit 1 (~24 years prior to MRI)  Visit 5 (Concurrent with MRI) 
  beta (95%CI) p-value beta (95%CI) p-value 
Triglycerides         
500+ mg/dL -0.1893 (-0.7397, 0.3611) 0.50 0.635 (-0.3551, 1.6252) 0.21 
200-500 mg/dL 0.0462 (-0.0919, 0.1842) 0.51 0.0585 (-0.0609, 0.178) 0.34 
150-200 mg/dL -0.0388 (-0.1592, 0.0815)   0.0663 (-0.0392, 0.1718)   
<150 mg/dL 0 (ref) 0.53 0 (ref) 0.22 
LDL-c         
190+ mg/dL 0.0247 (-0.154, 0.2034) 0.79 -0.0277 (-0.3086, 0.2533) 0.85 
160-190 mg/dL -0.0192 (-0.1558, 0.1173) 0.78 -0.0452 (-0.2053, 0.1149) 0.58 
130-160 mg/dL -0.0388 (-0.1541, 0.0765) 0.51 -0.0035 (-0.1168, 0.1097) 0.95 
100-130 mg/dL -0.0452 (-0.1553, 0.0648) 0.42 0.0113 (-0.0749, 0.0975) 0.80 
<100 mg/dL 0 (ref)   0 (ref)   
HDL-c         
60+ mg/dL -0.0405 (-0.1698, 0.0888) 0.54 -0.0357 (-0.1564, 0.085) 0.56 
40-60 mg/dL -0.0472 (-0.1565, 0.0621) 0.40 -0.0487 (-0.151, 0.0537) 0.35 
<40 mg/dL 0 (ref)   0 (ref)   
Total Cholesterol         
240+ mg/dL 0.0025 (-0.1027, 0.1076) 0.96 0.0383 (-0.0837, 0.1603) 0.54 
200-240 mg/dL 0.0203 (-0.0683, 0.1088) 0.65 -0.018 (-0.1064, 0.0704) 0.69 
<200 mg/dL 0 (ref)   0 (ref)   
Glucose         
126+ mg/dL 0.3066 (0.0184, 0.5949) 0.04 0.0184 (-0.0997, 0.1365) 0.76 
100-126 mg/dL 0.0672 (-0.0184, 0.1529) 0.12 0.0898 (0.01, 0.1696) 0.03 
<100 mg/dL 0 (ref)   0 (ref)   
DBP         
80+ mm Hg 0.1713 (0.0014, 0.3412) 0.05 0.2062 (0.0656, 0.3468) 0.004 
60-80 mm Hg 0.1459 (0.0051, 0.2868) 0.04 0.0921 (0.0099, 0.1743) 0.03 
<60 mm Hg 0 (ref)   0 (ref)   
SBP     
140+ mm Hg 0.0961 (-0.079, 0.2712) 0.28 0.2691 (0.1736, 0.3646) <0.0001 
120-140 mm Hg 0.1216 (0.0291, 0.2141) 0.01 0.1216 (0.0396, 0.2036) 0.004 
<120 mm Hg 0 (ref)   0 (ref) Visit 5 
Abbreviations:   ARIC-NCS, Atherosclerosis Risk in Communities Study Neurocognitive Study; DBP, 
diastolic blood pressure;  HDL-c, high density lipoprotein cholesterol;  LDL-c, low density lipoprotein 
cholesterol; MD, mean diffusivity; SBP, systolic blood pressure.   
*Fully adjusted model including age, gender, education, race/center, BMI, the square of BMI, smoking status, 
APOE E4, the other vascular risk factors, antihypertensive medication use, antidiabetic medication use, and 
lipid-lowering medications. 
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